These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21356074)

  • 1. Prenatal manifestation and management of a mother and child affected by spondyloperipheral dysplasia with a C-propeptide mutation in COL2A1: case report.
    Bedeschi MF; Bianchi V; Gentilin B; Colombo L; Natacci F; Giglio S; Andreucci E; Trespidi L; Acaia B; Furga AS; Lalatta F
    Orphanet J Rare Dis; 2011 Feb; 6():7. PubMed ID: 21356074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1.
    Zankl A; Zabel B; Hilbert K; Wildhardt G; Cuenot S; Xavier B; Ha-Vinh R; Bonafé L; Spranger J; Superti-Furga A
    Am J Med Genet A; 2004 Aug; 129A(2):144-8. PubMed ID: 15316962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies.
    Zankl A; Neumann L; Ignatius J; Nikkels P; Schrander-Stumpel C; Mortier G; Omran H; Wright M; Hilbert K; Bonafé L; Spranger J; Zabel B; Superti-Furga A
    Am J Med Genet A; 2005 Feb; 133A(1):61-7. PubMed ID: 15643621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spondyloperipheral dysplasia as the mosaic form of platyspondylic lethal skeletal dyplasia torrance type in mother and fetus with the same COL2A1 mutation.
    Désir J; Cassart M; Donner C; Coucke P; Abramowicz M; Mortier G
    Am J Med Genet A; 2012 Aug; 158A(8):1948-52. PubMed ID: 22495950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of one novel mutation in the C-propeptide of COL2A1 in a Chinese family with spondyloperipheral dysplasia.
    Zhang Z; Zhao SC; He JW; Fu WZ; Zhang CQ; Zhang ZL
    Gene; 2013 Jun; 522(1):107-10. PubMed ID: 23545312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Czech dysplasia metatarsal type: another type II collagen disorder.
    Hoornaert KP; Marik I; Kozlowski K; Cole T; Le Merrer M; Leroy JG; Coucke PJ; Sillence D; Mortier GR
    Eur J Hum Genet; 2007 Dec; 15(12):1269-75. PubMed ID: 17726487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENU-induced missense mutation in the C-propeptide coding region of Col2a1 creates a mouse model of platyspondylic lethal skeletal dysplasia, Torrance type.
    Furuichi T; Masuya H; Murakami T; Nishida K; Nishimura G; Suzuki T; Imaizumi K; Kudo T; Ohkawa K; Wakana S; Ikegawa S
    Mamm Genome; 2011 Jun; 22(5-6):318-28. PubMed ID: 21538020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid molecular prenatal diagnosis of spondyloepiphyseal dysplasia congenita by PCR-SSP assay.
    Cui YX; Xia XY; Bu Y; Zhou GH; Yang B; Lu HY; Shi YC; Pan LJ; Huang YF; Li XJ
    Genet Test; 2008 Dec; 12(4):533-6. PubMed ID: 19072565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia.
    Zabel B; Hilbert K; Stöss H; Superti-Furga A; Spranger J; Winterpacht A
    Am J Med Genet; 1996 May; 63(1):123-8. PubMed ID: 8723097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent c.G1636A (p.G546S) mutation of COL2A1 in a Chinese family with skeletal dysplasia and different metaphyseal changes: a case report.
    Chen J; Ma X; Zhou Y; Li G; Guo Q
    BMC Pediatr; 2017 Jul; 17(1):175. PubMed ID: 28738883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spondyloepiphyseal dysplasia Maroteaux type: report of three patients from two families and exclusion of type II collagen defects.
    Nishimura G; Kizu R; Kijima Y; Sakai K; Kawaguchi Y; Kimura T; Matsushita I; Shirahama S; Ikeda T; Ikegawa S; Hasegawa T
    Am J Med Genet A; 2003 Aug; 120A(4):498-502. PubMed ID: 12884428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype.
    Terhal PA; Nievelstein RJ; Verver EJ; Topsakal V; van Dommelen P; Hoornaert K; Le Merrer M; Zankl A; Simon ME; Smithson SF; Marcelis C; Kerr B; Clayton-Smith J; Kinning E; Mansour S; Elmslie F; Goodwin L; van der Hout AH; Veenstra-Knol HE; Herkert JC; Lund AM; Hennekam RC; Mégarbané A; Lees MM; Wilson LC; Male A; Hurst J; Alanay Y; Annerén G; Betz RC; Bongers EM; Cormier-Daire V; Dieux A; David A; Elting MW; van den Ende J; Green A; van Hagen JM; Hertel NT; Holder-Espinasse M; den Hollander N; Homfray T; Hove HD; Price S; Raas-Rothschild A; Rohrbach M; Schroeter B; Suri M; Thompson EM; Tobias ES; Toutain A; Vreeburg M; Wakeling E; Knoers NV; Coucke P; Mortier GR
    Am J Med Genet A; 2015 Mar; 167A(3):461-75. PubMed ID: 25604898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platyspondylic lethal dysplasia torrance type with a heterozygous mutation in the triple helical domain of COL2A1 in two sibs from phenotypically normal parents.
    Okamoto T; Nagaya K; Asai H; Tsuchida E; Nohara F; Hayashi T; Yamashita A; Nishimura G; Azuma H
    Am J Med Genet A; 2012 Aug; 158A(8):1953-6. PubMed ID: 22711552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type.
    Nishimura G; Nakashima E; Mabuchi A; Shimamoto K; Shimamoto T; Shimao Y; Nagai T; Yamaguchi T; Kosaki R; Ohashi H; Makita Y; Ikegawa S
    J Med Genet; 2004 Jan; 41(1):75-9. PubMed ID: 14729840
    [No Abstract]   [Full Text] [Related]  

  • 15. Short stature, platyspondyly, hip dysplasia, and retinal detachment: an atypical type II collagenopathy caused by a novel mutation in the C-propeptide region of COL2A1: a case report.
    Sangsin A; Srichomthong C; Pongpanich M; Suphapeetiporn K; Shotelersuk V
    BMC Med Genet; 2016 Dec; 17(1):96. PubMed ID: 27955642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal deterioration in COL2A1-related spondyloepiphyseal dysplasia occurs prior to osteoarthritis.
    Rolvien T; Yorgan TA; Kornak U; Hermans-Borgmeyer I; Mundlos S; Schmidt T; Niemeier A; Schinke T; Amling M; Oheim R
    Osteoarthritis Cartilage; 2020 Mar; 28(3):334-343. PubMed ID: 31958497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysspondyloenchondromatosis (DSC) associated with COL2A1 mutation: Clinical and radiological overlap with spondyloepimetaphyseal dysplasia-Strudwick type (SEMD-S).
    Merrick B; Calder A; Wakeling E
    Am J Med Genet A; 2015 Dec; 167A(12):3103-7. PubMed ID: 26250472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.
    Forzano F; Lituania M; Viassolo A; Superti-Furga V; Wildhardt G; Zabel B; Faravelli F
    Am J Med Genet A; 2007 Dec; 143A(23):2815-20. PubMed ID: 17994563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies.
    Barat-Houari M; Sarrabay G; Gatinois V; Fabre A; Dumont B; Genevieve D; Touitou I
    Hum Mutat; 2016 Jan; 37(1):7-15. PubMed ID: 26443184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Achondrogenesis type II-hypochondrogenesis: radiological features.Case report].
    Delgado Carrasco J; Casanova Morcillo A; Zabalza Alvillos M; Ayala Garcés A
    An Esp Pediatr; 2001 Dec; 55(6):553-7. PubMed ID: 11730591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.